PRECISION BIOSCIENCES INC Earnings Per Share (Basic)
PRECISION BIOSCIENCES INC (DTIL) reported Earnings Per Share (Basic) of -$1.26 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasic · last filed 2026-08-06
- PRECISION BIOSCIENCES INC earnings per share, basic for the quarter ending 2026-06-30 was -$1.26.
- PRECISION BIOSCIENCES INC earnings per share, basic for the quarter ending 2026-03-31 was -$0.75.
- PRECISION BIOSCIENCES INC earnings per share, basic for the quarter ending 2025-12-31 was $1.05.
- PRECISION BIOSCIENCES INC earnings per share, basic for the quarter ending 2025-09-30 was -$1.84.
- PRECISION BIOSCIENCES INC earnings per share, basic for fiscal 2025 was -$3.56, a 439.05% decline from fiscal 2024.
- PRECISION BIOSCIENCES INC earnings per share, basic for fiscal 2024 was $1.05.
- PRECISION BIOSCIENCES INC earnings per share, basic for fiscal 2023 was -$15.96.
- PRECISION BIOSCIENCES INC earnings per share, basic for fiscal 2022 was -$38.10.
| Period end | Earnings Per Share, Basic 3 month | Earnings Per Share, Basic 3 month as first filed | Earnings Per Share, Basic 6 month | Earnings Per Share, Basic 6 month as first filed | Earnings Per Share, Basic 9 month | Earnings Per Share, Basic 9 month as first filed | Earnings Per Share, Basic 12 month | Earnings Per Share, Basic 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | -$1.26 10-Q · filed 2026-08-06 | -$2.02 10-Q · filed 2026-08-06 | -$1.33 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.59 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2026-03-31 | -$0.75 10-Q · filed 2026-05-05 | $0.08 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$1.08 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.62 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-12-31 | $1.05 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$0.11 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$1.80 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$3.56 10-K · filed 2026-03-12 | ||||
| 2025-09-30 | -$1.84 10-Q · filed 2025-11-03 | -$3.96 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$6.14 10-Q · filed 2025-11-03 | -$8.33 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-06-30 | -$2.13 10-Q · filed 2026-08-06 | -$4.33 10-Q · filed 2026-08-06 | -$6.54 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$8.78 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2025-03-31 | -$2.21 10-Q · filed 2026-05-05 | -$4.43 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$6.68 derived: net income ÷ weighted average shares · filed 2026-08-06 | -$2.79 derived: net income ÷ weighted average shares · filed 2026-08-06 | ||||
| 2024-12-31 | -$2.22 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$4.47 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$0.19 derived: net income ÷ weighted average shares · filed 2026-04-08 | $1.05 10-K · filed 2026-03-12 | ||||
| 2024-09-30 | -$2.25 10-Q · filed 2025-11-03 | $2.29 derived: net income ÷ weighted average shares · filed 2025-11-03 | $3.87 10-Q · filed 2025-11-03 | $1.48 derived: net income ÷ weighted average shares · filed 2026-04-08 | ||||
| 2024-06-30 | $4.70 10-Q · filed 2025-08-07 | $6.87 10-Q · filed 2025-08-07 | $4.68 derived: net income ÷ weighted average shares · filed 2026-04-08 | $3.41 derived: net income ÷ weighted average shares · filed 2026-04-08 | ||||
| 2024-03-31 | $1.70 10-Q · filed 2025-05-15 | -$1.70 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$3.67 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$6.62 derived: net income ÷ weighted average shares · filed 2026-04-08 | ||||
| 2023-12-31 | -$4.06 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$6.21 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$9.33 derived: net income ÷ weighted average shares · filed 2026-04-08 | -$15.96 10-K · filed 2025-03-26 | ||||
| 2023-09-30 | -$2.10 10-Q · filed 2024-11-04 | -$0.07 10-Q · filed 2023-11-07 | -$5.23 derived: net income ÷ weighted average shares · filed 2024-11-04 | -$11.90 10-Q · filed 2024-11-04 | -$0.40 10-Q · filed 2023-11-07 | $1.35 derived: net income ÷ weighted average shares · filed 2024-11-04 | ||
| 2023-06-30 | -$3.13 10-Q · filed 2024-08-01 | -$0.10 10-Q · filed 2023-08-04 | -$9.84 10-Q · filed 2024-08-01 | -$0.33 10-Q · filed 2023-08-04 | $0.89 derived: net income ÷ weighted average shares · filed 2024-11-04 | $3.24 derived: net income ÷ weighted average shares · filed 2024-11-04 | ||
| 2023-03-31 | -$6.75 10-Q · filed 2024-05-13 | -$0.23 10-Q · filed 2023-05-09 | $0.48 derived: net income ÷ weighted average shares · filed 2024-11-04 | $2.04 derived: net income ÷ weighted average shares · filed 2024-11-04 | $9.41 derived: net income ÷ weighted average shares · filed 2024-11-04 | |||
| 2022-12-31 | $0.12 derived: net income ÷ weighted average shares · filed 2024-03-27 | $0.89 derived: net income ÷ weighted average shares · filed 2024-03-27 | $5.02 derived: net income ÷ weighted average shares · filed 2024-03-27 | -$38.10 10-K · filed 2024-03-27 | -$1.27 10-K · filed 2023-03-09 | |||
| 2022-09-30 | -$0.22 10-Q · filed 2023-11-07 | -$0.61 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.04 10-Q · filed 2023-11-07 | -$1.40 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-06-30 | -$0.46 10-Q · filed 2023-08-04 | -$0.92 10-Q · filed 2023-08-04 | -$1.29 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.49 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2022-03-31 | -$0.46 10-Q · filed 2023-05-09 | -$0.83 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$1.02 derived: net income ÷ weighted average shares · filed 2023-11-07 | -$0.67 derived: net income ÷ weighted average shares · filed 2023-11-07 | ||||
| 2021-12-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.56 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.20 derived: net income ÷ weighted average shares · filed 2023-03-09 | -$0.52 10-K · filed 2023-03-09 | ||||
| 2021-09-30 | -$0.19 10-Q · filed 2022-11-08 | $0.18 derived: net income ÷ weighted average shares · filed 2022-11-08 | -$0.14 10-Q · filed 2022-11-08 | |||||
| 2021-06-30 | $0.38 10-Q · filed 2022-08-08 | $0.05 10-Q · filed 2022-08-08 | ||||||
| 2020-06-30 | -$0.63 10-Q · filed 2021-08-12 | -$1.15 10-Q · filed 2021-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Outlook Therapeutics, Inc. (OTLK) | United States | $0.162B | -4.90 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |